In 2012, the Chinese market for neurological devices was valued at over $528 million.
The Chinese market for neurological devices includes:
fixed pressure CSF shunts, adjustable pressure CSF shunts, bare platinum detachable coils, coated detachable coils, liquid embolics, neurovascular catheters, neurovascular stents, neurovascular guide wires, deep brain stimulators (DBS), spinal cord stimulators (SCS), sacral nerve stimulators (SNS), intrathecal pumps, frame-based stereotactic systems, frameless stereotactic systems and aneurysm clips.
Market growth will be driven by the continued acceptance of aneurysm treatment procedures, arteriovenous malformation (AVM) treatment procedures and frameless stereotactic treatment for cranial tumors.
What You Need to Know:
The neurovascular stent market is expected to see significant growth with the recent approval of flow diversion devices.
The Chinese neurovascular stent market includes, among others, the Enterprise™ stent from Codman Neurovascular and the Neuroform® stent from Boston Scientific. Covidien’s Pipeline™ device is the first and only flow diversion device approved by the Food and Drug Administration (FDA). Flow diversion and other stent-like devices have the potential to transform the neurovascular stent market regarding the treatment of intracranial aneurysms. (Click here to get the latest info and request a free report synopsis) This would move the market away from coil embolization and towards parent vessel reconstruction and flow diversion. It is expected that stenting procedure numbers will increase rapidly over the forecast period due to proven product benefit and educational support provided by the manufacturer.